Cannabis antagonists: a new era of social psychopharmacology?
Nutt
David
D
D019440:Anti-Obesity Agents / Q000627:therapeutic use*; D002186:Cannabinoids / Q000037:antagonists & inhibitors*; D002188:Cannabis / Q000009:adverse effects; D006801:Humans; D002189:Marijuana Abuse / Q000523:psychology; D009765:Obesity / Q000188:drug therapy; D010880:Piperidines / Q000627:therapeutic use*; D011600:Psychopharmacology / Q000639:trends*; D011720:Pyrazoles / Q000627:therapeutic use*; D000077285:Rimonabant
D019440:Anti-Obesity Agents; D002186:Cannabinoids; D010880:Piperidines; D011720:Pyrazoles; D000077285:Rimonabant